Beckman Coulter Diagnostics
Private Company
Funding information not available
Overview
Beckman Coulter Diagnostics, a Danaher company, is a premier provider of in-vitro diagnostic (IVD) systems, instruments, and reagents for clinical laboratories globally. Its mission is to deliver actionable diagnostic insights through a deeply integrated portfolio spanning chemistry, immunoassay, hematology, and workflow informatics. The company's strategy is anchored in continuous innovation within its core lab franchises, expansion into high-growth areas like sepsis management and digital hematology, and the relentless operational discipline of the Danaher Business System.
Technology Platform
Integrated ecosystem of automated analyzers (chemistry, immunoassay, hematology), specialized reagents, laboratory automation systems, and advanced informatics/clinical decision support software for the core clinical laboratory.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in a highly consolidated market competing directly with Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Sysmex, and Thermo Fisher. Its competitive edge lies in its integrated core lab portfolio, Danaher's operational excellence, and a focused strategy on high-growth disease state solutions like sepsis and digital hematology.